How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania

BMC Medical Ethics

Volumn 11, Issue 1, 2010, Pages

  Vallely, Andrew ^a,b   Lees, Shelley ^a,c   Shagi, Charles ^b   Kasindi, Stella ^b   Soteli, Selephina ^b   Kavit, Natujwa ^b   Vallely, Lisa ^c   McCormack, Sheena ^d   Pool, Robert ^e   Hayes, Richard J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b African Medical and Research Foundation Mwanza   (Tanzania)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

^e UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIINFECTIVE AGENT; MESYLIC ACID DERIVATIVE; NAPHTHALENESULFONIC ACID, POLYMER WITH FORMALDEHYDE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; COMPREHENSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHICS; FEMALE; GEL; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMED CONSENT; INTRAVAGINAL DRUG ADMINISTRATION; MIDDLE AGED; PHASE 3 CLINICAL TRIAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECALL; RESEARCH ETHICS; TANZANIA; TIME; TREATMENT OUTCOME; VULNERABLE POPULATION;

ADMINISTRATION, INTRAVAGINAL; ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS; COMPREHENSION; ETHICS, RESEARCH; FEMALE; GELS; HIV INFECTIONS; HUMANS; INFORMED CONSENT; MENTAL RECALL; MESYLATES; MIDDLE AGED; QUESTIONNAIRES; TANZANIA; THERAPEUTIC HUMAN EXPERIMENTATION; TIME FACTORS; TREATMENT OUTCOME; VULNERABLE POPULATIONS; YOUNG ADULT;

EID: 77953305400     PISSN: None     EISSN: 14726939     Source Type: Journal    
DOI: 10.1186/1472-6939-11-10     Document Type: Article

References (40)

1. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. P Lurie SM Wolfe, N Engl J Med 1997 337 12 853 856 10.1056/NEJM199709183371212 9295246
2. Ethical considerations in international HIV vaccine trials: summary of a consultative process conducted by the Joint United Nations Programme on HIV/AIDS (UNAIDS). D Guenter J Esparza R Macklin, J Med Ethics 2000 26 1 37 43 10.1136/jme.26.1.37 10701170
3. What makes clinical research in developing countries ethical? The benchmarks of ethical research. EJ Emanuel D Wendler J Killen C Grady, J Infect Dis 2004 189 930 937 10.1086/381709 14976611
4. Ethical issues in HIV/AIDS research. V Muthuswamy, Indian J Med Res 2005 121 4 601 610 15817966
5. Enrolling women into HIV preventive vaccine trials: an ethical imperative but a logistical challenge. E Mills S Nixon S Singh S Dolma A Nayyar S Kapoor, PLoS Med 2006 3 3 94 10.1371/journal.pmed.0030094 16478295
6. HIV, research, ethics and women. V Salvi K Damania, J Postgrad Med 2006 52 3 161 162 16855313
7. Community preparedness for HIV vaccine trials in the Democratic Republic of Congo. J Olin J Kokolamami F Lepira K Mwandaglirwa B Mupenda ML Ndongala S Maman R Bollinger J Nachega J Mokili, Cult Health Sex 2006 8 6 529 544 10.1080/13691050600888434 17050384
8. Microbicide research in developing countries: have we given the ethical concerns due consideration? K Moodley, BMC Medical Ethics 2007 8 1 10 10.1186/1472-6939-8-10 17877834
9. Ethical issues in the NIMH Collaborative HIV/STD Prevention Trial. NIMH, Aids 2007 21 Suppl 2 69 80 10.1097/01.aids.0000266459.49138.b3 17413266
10. Male circumcision and HIV prevention: ethical, medical and public health tradeoffs in low-income countries. S Rennie AS Muula D Westreich, J Med Ethics 2007 33 6 357 361 10.1136/jme.2006.019901 17526688
11. Epidemiological considerations in planning HIV preventive vaccine trials. J Esparza D Burke, AIDS 2001 15 Supp 5 49 S57 10.1097/00002030-200100005-00008 11816175
12. The epidemiological contribution to the preparation of field trials for HIV and STI vaccines: objectives and methods of feasibility studies. B Suligoi TM Wagner M Ciccozzi G Rezza, Vaccine 2005 23 12 1437 1445 10.1016/j.vaccine. 2004.10.002 15670878
13. Coercion and informed consent in research involving prisoners. DJ Moser S Arndt JE Kanz ML Benjamin JD Bayless RL Reese JS Paulsen MA Flaum, Compr Psychiatry 2004 45 1 1 9 10.1016/j.comppsych.2003.09.009 14671730
14. Understanding of informed consent in a low-income setting: three case studies from the Kenyan coast. CS Molyneux N Peshua K Marsh, Soc Sci Med 2004 59 2547 2559 10.1016/j.socscimed.2004.03.037 15474208
15. Should desperate volunteers be included in randomised controlled trials? P Allmark S Mason, J Med Ethics 2006 32 9 548 553 10.1136/jme.2005.014282 16943339
16. Consenting of the vulnerable: the informed consent procedure in advanced cancer patients in Mexico. EL Verastegui, BMC Med Ethics 2006 7 13 10.1186/1472-6939-7-13 17166274
17. "We have our protector": misperceptions of protection against HIV among participants in a microbicide efficacy trial. JE Mantell NS Morar L Myer G Ramjee, Am J Public Health 2006 96 6 1073 1077 10.2105/AJPH.2004.047514 16670239
18. The use of an educational video during informed consent in an HIV clinical trial in Haiti. P Joseph BR Schackman R Horwitz S Nerette RI Verdier D Dorsainvil H Theodore M Ascensio K Henrys PF Wright, et al. J Acquir Immune Defic Syndr 2006 42 5 588 591 10.1097/01.qai.0000229998.59869.05 16837867
19. Use of community-based participatory research in preparing low income and homeless minority populations for future HIV vaccines. A Nyamathi D Koniak-Griffin L Tallen E Gonzalez-Figueroa L Levson Y Mosley E Dominick NL Anderson, J Interprof Care 2004 18 4 369 380 10.1080/13561820400011735 15801552
20. Perceptions of a community sample about participation in future HIV vaccine trials in south India. AM Nyamathi M Suhadev S Swaminathan JL Fahey, AIDS Behav 2007 11 4 619 627 10.1007/s10461-006-9173-8 17016758
21. The role of community advisory boards: involving communities in the informed consent process. RP Strauss S Sengupta SC Quinn J Goeppinger C Spaulding SM Kegeles G Millett, Am J Public Health 2001 91 12 1938 1943 10.2105/AJPH.91.12.1938 11726369
22. Comprehension during informed consent in a less developed country. DW Fitzgerald C Marotte RI Verdier WD Johnson JW Pape, Lancet 2002 360 1301 1302 10.1016/S0140-6736(02)11338-9 12414207
23. Improving the quality of consent to randomised controlled trials by using continuous consent and clinician training in the consent process. P Allmark S Mason, J Med Ethics 2006 32 8 439 443 10.1136/jme.2005.013722 16877621
24. Microbicides Development Programme. 2005 http://www.mdp.mrc.ac.uk/
25. Microbicides Development Programme, Tanzania. Baseline characteristics of an occupational cohort and re-attendance at three months. A Vallely S Kasindi IR Hambleton L Knight T Chirwa R Balira J Changalucha D Watson-Jones D Everett A Gavyole, et al. Sexually Transmitted Diseases 2007 34 9 638 643 10.1097/OLQ.0b013e3180325120 17717482
26. A typology of groups at risk of HIV/STI in a gold mining town in north-western Tanzania. N Desmond CF Allen S Clift B Justine J Mzugu ML Plummer D Watson-Jones DA Ross, Soc Sci Med 2005 60 8 1739 1749 10.1016/j.socscimed. 2004.08.027 15686806
27. Sexual relationship, condom use and risk perception among female bar workers in north-west Tanzania. Z Mgalla R Pool, AIDS Care 1997 9 4 407 416 10.1080/713613167 9337885
28. HIV-1 epidemic among female bar and hotel workers in northern Tanzania: risk factors and opportunities for prevention. S Kapiga N Sam J Shao, J Acquir Immune Defic Syndr 2002 29 4 409 417 11917247
29. Variations of HIV and STI prevalences within communities neighbouring new goldmines in Tanzania: importance for intervention design. S Clift A Anemona D Watson-Jones Z Kanga L Ndeki J Changalucha A Gavyole DA Ross, Sex Transm Infect 2003 79 4 307 312 10.1136/sti.79.4.307 12902582
30. Baseline survey of sexually transmitted infections in a cohort of female bar workers in Mbeya Region, Tanzania. G Riedner M Rusizoka O Hoffmann F Nichombe E Lyamuya D Mmbando L Maboko P Hay J Todd R Hayes, et al. Sex Transm Infect 2003 79 5 382 387 10.1136/sti.79.5.382 14573833
31. Sexual risk behaviour for women working in recreational venues in Mwanza, Tanzania: considerations for the acceptability and use of vaginal microbicide gels. S Lees N Desmond C Allen G Bugeke A Vallely D Ross, Cult Health Sex 2009 11 6 581 595 10.1080/13691050902721846 19444689
32. Microbicides development programme: placebo vaginal gel acceptability amongst women at high-risk of HIV in Mwanza, Tanzania. N Wandera S Lees J Wayomi N Desmond L Medard A Vallely C Allen RJ Hayes D Ross, AIDS 2006-XVI International AIDS Conference Abstract no MOPE0860. Toronto, Canada 2006
33. A model for community representation and participation in HIV prevention trials among women who engage in transactional sex in Africa. C Shagi A Vallely S Kasindi B Chiduo N Desmond S Soteli N Kavit L Vallely S Lees R Hayes, et al. AIDS Care 2008 20 9 1039 1049 10.1080/09540120701842803 18825513
34. The benefits of participatory methodologies to develop effective community dialogue in the context of a microbicide trial feasibility study in Mwanza, Tanzania. A Vallely C Shagi S Kasindi N Desmond S Lees B Chiduo R Hayes C Allen D Ross, BMC Public Health 2007 7 133 10.1186/1471-2458-7-133 17697333
35. Microbicides Development Programme: Engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania. A Vallely C Shagi S Lees K Shapiro J Masanja L Nikolau J Kazimoto S Soteli C Moffat J Changalucha, et al. BMC Med Ethics 2009 10 17 10.1186/1472-6939-10-17 19814830
36. Mapping the Standards of Care at Microbicide Clinical Trial Sites. L Heise K Shapiro K West Slevin, Washington, DC: Global Campaign for Microbicides 2008
37. Human immunodeficiency virus type 1 among bar and hotel workers in northern Tanzania: the role of alcohol, sexual behavior, and herpes simplex virus type 2. TT Ao NE Sam EJ Masenga GRr Seage SH Kapiga, Sex Transm Dis 2006 33 3 163 169 10.1097/01.olq.0000187204.57006.b3 16505740
38. Women who sell sex in a Ugandan trading town: life histories, survival strategies and risk. M Gysels R Pool B Nnalusiba, Soc Sci Med 2002 54 179 192 10.1016/S0277-9536(01)00027-2 11824924
39. Obtaining voluntary consent for research in desperately ill patients. CL Bosk, Medical Care 2002 40 Suppl 9 &2264 68 12226587
40. The therapeutic misconception: problems and solutions. CW Lidz PS Appelbaum, Medical Care 2002 40 Suppl 9 &2255 63 12226586